AusDiagnostics, an Australian manufacturer specializing in in vitro diagnostic reagents and robotic systems for molecular-based syndromic testing, excels in highly multiplexed PCR technology. Their patented MT-PCR method simplifies and enhances testing for multiple target genes with a single product, facilitating more informed diagnostic decisions in human health, animal diagnostics, and applied testing. With one of the industry's most comprehensive panel suites, AusDiagnostics addresses a wide range of testing needs, including respiratory, enteric, STI, antimicrobial resistance, dermatophytes, and more. As a wholly owned subsidiary of R-Biopharm AG, AusDiagnostics serves laboratories and hospitals globally from its headquarters in Australia, with additional offices in New Zealand and the United States.